Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Samama

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Revue Medicale De Bruxelles|July 1, 1995
[The treatment of deep venous thrombosis with low-molecular-weight heparin]M M Samama, A Achkar, M H Horellou
Acta Haematologica|September 11, 2001
The thrombophilic state in cancer patientsI Gouin-Thibault, A Achkar, M M Samama
Journal Des Maladies Vasculaires|January 1, 1996
[Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin]P Chigot, C De Gennes, M M Samama
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 26, 2000
Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparinS Meddahi, L Bara, H Fessi, et al.
Annales De Biologie Clinique|January 1, 1995
[Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin]J L Renier, H Baufine-Ducrocq, M M Samama
Journal of Thrombosis and Haemostasis : JTH|October 15, 2010
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro studyA Tripodi, V Chantarangkul, C Guinet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1996
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemiasD Zitoun, L Bara, A Basdevant, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Biological markers for acute phase hemostasis in coronary thrombosis]I Elalamy, G Gerotziafas, R Dumaine, et al.
Journal Des Maladies Vasculaires|June 25, 2013
[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays]M M Samama, J Conard, A Lillo-Le Louët
Thrombosis Research|May 1, 1997
Platelet aggregation by IgG anti-streptokinase and anisoylated plasminogen-streptokinase activator complex: heterogenous responses in platelet-rich plasma but not in washed plateletsM Abdelouahed, I Elalamy, M M Samama, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Revue Medicale De Bruxelles|July 1, 1995
[The treatment of deep venous thrombosis with low-molecular-weight heparin]M M Samama, A Achkar, M H Horellou
Acta Haematologica|September 11, 2001
The thrombophilic state in cancer patientsI Gouin-Thibault, A Achkar, M M Samama
Journal Des Maladies Vasculaires|January 1, 1996
[Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin]P Chigot, C De Gennes, M M Samama
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 26, 2000
Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparinS Meddahi, L Bara, H Fessi, et al.
Annales De Biologie Clinique|January 1, 1995
[Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin]J L Renier, H Baufine-Ducrocq, M M Samama
Journal of Thrombosis and Haemostasis : JTH|October 15, 2010
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro studyA Tripodi, V Chantarangkul, C Guinet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1996
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemiasD Zitoun, L Bara, A Basdevant, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 26, 2002
[Biological markers for acute phase hemostasis in coronary thrombosis]I Elalamy, G Gerotziafas, R Dumaine, et al.
Journal Des Maladies Vasculaires|June 25, 2013
[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays]M M Samama, J Conard, A Lillo-Le Louët
Thrombosis Research|May 1, 1997
Platelet aggregation by IgG anti-streptokinase and anisoylated plasminogen-streptokinase activator complex: heterogenous responses in platelet-rich plasma but not in washed plateletsM Abdelouahed, I Elalamy, M M Samama, et al.
Pageof 19